Photobiomodulation therapy for the prevention of acute radiation dermatitis in breast cancer patients undergoing hypofractioned whole-breast irradiation (LABRA trial)
OBJECTIVESTo evaluate the efficacy of photobiomodulation therapy in breast cancer patients post-lumpectomy undergoing hypofractionated whole-breast irradiation (HF-WBI) for the prevention and management of acute radiodermatitis (ARD). MATERIALS AND METHODSA randomized, multicentric clinical trial (L...
Saved in:
Published in | Lasers in surgery and medicine Vol. 54; no. 3; pp. 374 - 383 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Report |
Language | English |
Published |
01.03.2022
|
Online Access | Get full text |
Cover
Loading…
Abstract | OBJECTIVESTo evaluate the efficacy of photobiomodulation therapy in breast cancer patients post-lumpectomy undergoing hypofractionated whole-breast irradiation (HF-WBI) for the prevention and management of acute radiodermatitis (ARD). MATERIALS AND METHODSA randomized, multicentric clinical trial (LABRA trial, NCT03924011) was set up at the Limburg Oncology Center, including the Jessa Hospital (Hasselt, BE) and Ziekenhuis Oost-Limburg (Genk, BE). A total of 71 breast cancer patients planned to undergo HF-WBI were randomized to one of the two study arms: the control group (n = 32) or the PBM group (n = 39). The PBM group received the standard institutional skincare combined with PBM (2×/week) during the complete radiotherapy (RT) course. Patients in the control group received the standard skincare combined with placebo treatment (2x/week). Patients' skin reactions were evaluated weekly during the RT treatment by using the modified version of the Radiation Therapy Oncology Group (RTOG) criteria. RESULTSAt week 3 of RT, one patient presented a grade 2 and one patient a grade 3 skin reaction in the control group, while in the PBM group, all patients still presented grade 1 ARD. At the final RT session 28% of the patients presenting grade 2-3 ARD, while in the PBM group 10% presented grade 2 and no grade 3 ARD. PBM reduced the incidence of severe ARD by 18%. However, the difference was not significant (p = 0.053). CONCLUSIONBased on the LABRA trial results, PBM seems not able to reduce the incidence of severe ARD in breast cancer patients undergoing HF-WBI. Research in a larger patient population is recommended. |
---|---|
AbstractList | OBJECTIVESTo evaluate the efficacy of photobiomodulation therapy in breast cancer patients post-lumpectomy undergoing hypofractionated whole-breast irradiation (HF-WBI) for the prevention and management of acute radiodermatitis (ARD). MATERIALS AND METHODSA randomized, multicentric clinical trial (LABRA trial, NCT03924011) was set up at the Limburg Oncology Center, including the Jessa Hospital (Hasselt, BE) and Ziekenhuis Oost-Limburg (Genk, BE). A total of 71 breast cancer patients planned to undergo HF-WBI were randomized to one of the two study arms: the control group (n = 32) or the PBM group (n = 39). The PBM group received the standard institutional skincare combined with PBM (2×/week) during the complete radiotherapy (RT) course. Patients in the control group received the standard skincare combined with placebo treatment (2x/week). Patients' skin reactions were evaluated weekly during the RT treatment by using the modified version of the Radiation Therapy Oncology Group (RTOG) criteria. RESULTSAt week 3 of RT, one patient presented a grade 2 and one patient a grade 3 skin reaction in the control group, while in the PBM group, all patients still presented grade 1 ARD. At the final RT session 28% of the patients presenting grade 2-3 ARD, while in the PBM group 10% presented grade 2 and no grade 3 ARD. PBM reduced the incidence of severe ARD by 18%. However, the difference was not significant (p = 0.053). CONCLUSIONBased on the LABRA trial results, PBM seems not able to reduce the incidence of severe ARD in breast cancer patients undergoing HF-WBI. Research in a larger patient population is recommended. |
Author | Claes, Stefan Lodewijckx, Joy Pannekoeke, Luc Mebis, Jeroen Van de Werf, Evelyn Timmermans, An Puts, Sofie Govers, Mieke Robijns, Jolien Van Bever, Leen Maes, Annelies Bulens, Paul Vanmechelen, Sofie Noé, Leen |
Author_xml | – sequence: 1 givenname: Jolien surname: Robijns fullname: Robijns, Jolien – sequence: 2 givenname: Joy surname: Lodewijckx fullname: Lodewijckx, Joy – sequence: 3 givenname: Sofie surname: Puts fullname: Puts, Sofie – sequence: 4 givenname: Sofie surname: Vanmechelen fullname: Vanmechelen, Sofie – sequence: 5 givenname: Leen surname: Van Bever fullname: Van Bever, Leen – sequence: 6 givenname: Stefan surname: Claes fullname: Claes, Stefan – sequence: 7 givenname: Luc surname: Pannekoeke fullname: Pannekoeke, Luc – sequence: 8 givenname: An surname: Timmermans fullname: Timmermans, An – sequence: 9 givenname: Leen surname: Noé fullname: Noé, Leen – sequence: 10 givenname: Mieke surname: Govers fullname: Govers, Mieke – sequence: 11 givenname: Evelyn surname: Van de Werf fullname: Van de Werf, Evelyn – sequence: 12 givenname: Annelies surname: Maes fullname: Maes, Annelies – sequence: 13 givenname: Paul surname: Bulens fullname: Bulens, Paul – sequence: 14 givenname: Jeroen surname: Mebis fullname: Mebis, Jeroen |
BookMark | eNqVjLFOwzAURS0EEi0w8AdvLEOKnTQNGQsCMTAgxF65zktj5PiZZwfUH-I7SaESM9O90j3nTsWxJ49CXCo5V1Lm1y7287xYVOWRmChZL7NaSXUqpjG-SSmLXFYT8fXcUaKNpZ6awelkyUPqkHXYQUu87xAYP9D_TNSCNkNCYN3YX7pB7seWbATrYcOoYwKjvUGGMA6jGWHwI7Yl67fQ7QK1rM1exgY-O3KYHTTLf7-zp9XtywoSW-2uzsVJq13Ei0OeidnD_evdYxaY3geMad3baNA57ZGGuM7LZV1UN9WiLP6BfgPr5Gmz |
ContentType | Report |
DBID | 7X8 |
DOI | 10.1002/lsm.23475 |
DatabaseName | MEDLINE - Academic |
DatabaseTitle | MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Engineering Physics |
EISSN | 1096-9101 |
EndPage | 383 |
GroupedDBID | --- .3N .GA 05W 0R~ 10A 1L6 1OB 1OC 1ZS 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 5GY 5RE 5VS 66C 702 7PT 7X8 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AAQQT AAWTL AAXRX AAZKR ABCQN ABCUV ABIJN ABJNI ABPVW ABQWH ABXGK ACAHQ ACCFJ ACCZN ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBD EBS EMOBN F00 F01 F04 F5P FUBAC G-S G.N GNP GODZA H.X HBH HGLYW HHY HHZ HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 QRW R.K RGB ROL RWI RX1 RYL SUPJJ SV3 TEORI UB1 V2E W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WRC WUP WVDHM WXI WXSBR XG1 XPP XV2 ZZTAW ~IA ~WT |
ID | FETCH-proquest_miscellaneous_25693787453 |
IngestDate | Fri Aug 16 08:51:39 EDT 2024 |
IsPeerReviewed | false |
IsScholarly | false |
Issue | 3 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-proquest_miscellaneous_25693787453 |
Notes | ObjectType-Case Study-2 ObjectType-News-4 content type line 59 SourceType-Reports-1 ObjectType-Report-1 ObjectType-Article-3 |
PQID | 2569378745 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_2569378745 |
PublicationCentury | 2000 |
PublicationDate | 20220301 |
PublicationDateYYYYMMDD | 2022-03-01 |
PublicationDate_xml | – month: 03 year: 2022 text: 20220301 day: 01 |
PublicationDecade | 2020 |
PublicationTitle | Lasers in surgery and medicine |
PublicationYear | 2022 |
SSID | ssj0003207 |
Score | 3.3915856 |
Snippet | OBJECTIVESTo evaluate the efficacy of photobiomodulation therapy in breast cancer patients post-lumpectomy undergoing hypofractionated whole-breast irradiation... |
SourceID | proquest |
SourceType | Aggregation Database |
StartPage | 374 |
Title | Photobiomodulation therapy for the prevention of acute radiation dermatitis in breast cancer patients undergoing hypofractioned whole-breast irradiation (LABRA trial) |
URI | https://search.proquest.com/docview/2569378745 |
Volume | 54 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fT9RAEN6coAk-IWpEwYyJDxjSs9ftD3lEAyGEAMEjubdLu92TQ68lbS8KfxB_pzM72x94JiIvTbPtbXOZL7OzO998I8T7ROGiGYQ7jg6jFDcok9CJvShw0mBHD2SkMWo2ap_H4cG5fzgKRr3ebYe1NK-Svrr5a13JQ6yKY2hXqpL9D8s2k-IA3qN98YoWxuu9bHx6kVckozTLU9uFa5vrqa4b9uCVlWjisDBWRAsoSI_ADKWaI9apYcUmRFCviAemdFErrpamU27xLaczhYvrq3xScC0E8dapua5jfzYt2nmpT8ju57PdbdMUpD5taMquqcKTPlhyTbZJYPyZ5KfCtMvMZikwUG6pQ3mqf04v1fdf_KzJCZzOK_P615yVlutGYjNNbFd2r-0ze9KBm-SG6tXX7J0ROeid7Zh136xBbWEqO75Ycvsfu6xL7pezsGKwAu2Pctb3pM9NXO6qch-fjPfPj47Gw73R8JFY9iLcUVLwfdbKlEnPjWrVKtf72Ey2sL6boGW4Kh7z7uqZ6OlsTTztSE-uiSeG-qvK5-J2EUVgUQSIIrqHFkWQT8CgCBprQ4simGbAcABGEdQoghZFcBdF0EURdFAEWwZDYDD04YXY2t8bfjlw6v86Rg9Faac40_m8HGNQjTEwtVWQL8VShjO_EuD7WntxOlCp-uS7yo0jOZChGyV-EARxNFgX7_453et7vPNGrLRQ2hBLVTHXmxhGVslbY8Pfh_OIMQ |
link.rule.ids | 786,790,4509,27956 |
linkProvider | Wiley-Blackwell |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Photobiomodulation+therapy+for+the+prevention+of+acute+radiation+dermatitis+in+breast+cancer+patients+undergoing+hypofractioned+whole-breast+irradiation+%28LABRA+trial%29&rft.jtitle=Lasers+in+surgery+and+medicine&rft.au=Robijns%2C+Jolien&rft.au=Lodewijckx%2C+Joy&rft.au=Puts%2C+Sofie&rft.au=Vanmechelen%2C+Sofie&rft.date=2022-03-01&rft.eissn=1096-9101&rft.volume=54&rft.issue=3&rft.spage=374&rft.epage=383&rft_id=info:doi/10.1002%2Flsm.23475&rft.externalDBID=NO_FULL_TEXT |